MiR-543 and MiR-590-3p Regulate Human Mesenchymal Stem Cell Aging Via Direct Targeting of AIMP3/p18
Overview
Authors
Affiliations
Previously, AIMP3 (aminoacyl-tRNAsynthetase-interacting multifunctional protein-3) was shown to be involved in the macromolecular tRNA synthetase complex or to act as a tumor suppressor. In this study, we report a novel role of AIMP3/p18 in the cellular aging of human mesenchymal stem cells (hMSCs). We found that AIMP3/p18 expression significantly increased in senescent hMSCs and in aged mouse bone marrow-derived MSCs (mBM-MSCs). AIMP3/p18 overexpression is sufficient to induce the cellular senescence phenotypes with compromised clonogenicity and adipogenic differentiation potential. To identify the upstream regulators of AIMP3/p18 during senescence, we screened for potential epigenetic regulators and for miRNAs. We found that the levels of miR-543 and miR-590-3p significantly decreased under senescence-inducing conditions, whereas the AIMP3/p18 protein levels increased. We demonstrate for the first time that miR-543 and miR-590-3p are able to decrease AIMP3/p18 expression levels through direct binding to the AIMP/p18 transcripts, which further compromised the induction of the senescence phenotype. Taken together, our data demonstrate that AIMP3/p18 regulates cellular aging in hMSCs possibly through miR-543 and miR-590-3p.
Dun Y, Zhang W, Du Y, Xie K, Liu Y, Li C J Cachexia Sarcopenia Muscle. 2024; 15(6):2574-2585.
PMID: 39276001 PMC: 11634493. DOI: 10.1002/jcsm.13600.
Genetic and Epigenetic Interactions Involved in Senescence of Stem Cells.
Iordache F, Petcu A, Alexandru D Int J Mol Sci. 2024; 25(17).
PMID: 39273655 PMC: 11396476. DOI: 10.3390/ijms25179708.
Zhu W, Du W, Duan R, Liu Y, Zong B, Jin X ACS Pharmacol Transl Sci. 2024; 7(3):743-756.
PMID: 38481697 PMC: 10928897. DOI: 10.1021/acsptsci.3c00293.
Consequences of Aging on Bone.
Zhang L, Guan Q, Wang Z, Feng J, Zou J, Gao B Aging Dis. 2023; 15(6):2417-2452.
PMID: 38029404 PMC: 11567267. DOI: 10.14336/AD.2023.1115.
Alkylating anticancer agents and their relations to microRNAs.
Biersack B Cancer Drug Resist. 2022; 2(1):1-17.
PMID: 35582140 PMC: 9019174. DOI: 10.20517/cdr.2019.09.